Graphical Summary: Validation of an automated, scalable comprehensive genomic profiling assay for hematologic malignancies
September 3, 2025
Key TakeawaysLabcorp Pan-Heme NGS demonstrates high sensitivity and specificity.This test may be used to help guide clinical decisions in both myeloid and lymphoid malignancies.
